These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 12392815)
21. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. Soh JW; Mao Y; Kim MG; Pamukcu R; Li H; Piazza GA; Thompson WJ; Weinstein IB Clin Cancer Res; 2000 Oct; 6(10):4136-41. PubMed ID: 11051267 [TBL] [Abstract][Full Text] [Related]
22. Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling. Li N; Xi Y; Tinsley HN; Gurpinar E; Gary BD; Zhu B; Li Y; Chen X; Keeton AB; Abadi AH; Moyer MP; Grizzle WE; Chang WC; Clapper ML; Piazza GA Mol Cancer Ther; 2013 Sep; 12(9):1848-59. PubMed ID: 23804703 [TBL] [Abstract][Full Text] [Related]
23. [Periplocin extracted from cortex periplocae induces apoptosis of SW480 cells through inhibiting the Wnt/beta-catenin signaling pathway]. Du YY; Liu X; Shan BE Ai Zheng; 2009 May; 28(5):456-60. PubMed ID: 19624870 [TBL] [Abstract][Full Text] [Related]
24. p38MAPK inhibitor SB203580 sensitizes human SNU-C4 colon cancer cells to exisulind-induced apoptosis. Lim SJ; Lee YJ; Lee E Oncol Rep; 2006 Nov; 16(5):1131-5. PubMed ID: 17016604 [TBL] [Abstract][Full Text] [Related]
25. Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells. Lim JT; Piazza GA; Pamukcu R; Thompson WJ; Weinstein IB Clin Cancer Res; 2003 Oct; 9(13):4972-82. PubMed ID: 14581372 [TBL] [Abstract][Full Text] [Related]
26. The sulindac derivatives OSI-461, OSIP486823, and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization. Xiao D; Deguchi A; Gundersen GG; Oehlen B; Arnold L; Weinstein IB Mol Cancer Ther; 2006 Jan; 5(1):60-7. PubMed ID: 16432163 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463 [TBL] [Abstract][Full Text] [Related]
28. Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone. Natsume H; Sasaki S; Kitagawa M; Kashiwabara Y; Matsushita A; Nakano K; Nishiyama K; Nagayama K; Misawa H; Masuda H; Nakamura H Biochem Biophys Res Commun; 2003 Sep; 309(2):408-13. PubMed ID: 12951064 [TBL] [Abstract][Full Text] [Related]
29. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Shtutman M; Zhurinsky J; Simcha I; Albanese C; D'Amico M; Pestell R; Ben-Ze'ev A Proc Natl Acad Sci U S A; 1999 May; 96(10):5522-7. PubMed ID: 10318916 [TBL] [Abstract][Full Text] [Related]
30. Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells. Hawcroft G; D'Amico M; Albanese C; Markham AF; Pestell RG; Hull MA Carcinogenesis; 2002 Jan; 23(1):107-14. PubMed ID: 11756231 [TBL] [Abstract][Full Text] [Related]
31. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333 [TBL] [Abstract][Full Text] [Related]
32. Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Pai R; Tarnawski AS; Tran T Mol Biol Cell; 2004 May; 15(5):2156-63. PubMed ID: 15004225 [TBL] [Abstract][Full Text] [Related]
33. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Emami KH; Nguyen C; Ma H; Kim DH; Jeong KW; Eguchi M; Moon RT; Teo JL; Kim HY; Moon SH; Ha JR; Kahn M Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12682-7. PubMed ID: 15314234 [TBL] [Abstract][Full Text] [Related]
34. Effect of nonsteroidal anti-inflammatory drugs on beta-catenin protein levels and catenin-related transcription in human colorectal cancer cells. Gardner SH; Hawcroft G; Hull MA Br J Cancer; 2004 Jul; 91(1):153-63. PubMed ID: 15188006 [TBL] [Abstract][Full Text] [Related]
35. Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells. Joe AK; Liu H; Xiao D; Soh JW; Pinto JT; Beer DG; Piazza GA; Thompson WJ; Weinstein IB J Exp Ther Oncol; 2003; 3(2):83-94. PubMed ID: 12822514 [TBL] [Abstract][Full Text] [Related]
36. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells. Narayanan BA; Narayanan NK; Desai D; Pittman B; Reddy BS Carcinogenesis; 2004 Dec; 25(12):2443-9. PubMed ID: 15297372 [TBL] [Abstract][Full Text] [Related]
37. Modulation of beta-catenin phosphorylation/degradation by cyclin-dependent kinase 2. Park CS; Kim SI; Lee MS; Youn CY; Kim DJ; Jho EH; Song WK J Biol Chem; 2004 May; 279(19):19592-9. PubMed ID: 14985333 [TBL] [Abstract][Full Text] [Related]
38. Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. Rockman SP; Currie SA; Ciavarella M; Vincan E; Dow C; Thomas RJ; Phillips WA J Biol Chem; 2001 Nov; 276(48):45113-9. PubMed ID: 11572874 [TBL] [Abstract][Full Text] [Related]
39. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling. Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625 [TBL] [Abstract][Full Text] [Related]
40. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways. Rice PL; Peters SL; Beard KS; Ahnen DJ Mol Cancer Ther; 2006 Mar; 5(3):746-54. PubMed ID: 16546990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]